Riskpilot← Back to searchSign inGet full accessBioImport 101 AB
ABActiveOrg 5592936347Solkraftsvägen 33Computer consultancy and computer facilities management activities · NACE 6220Est. 20200 employees
Revenue 2024
SEK 310K
+38% vs 2023
EBITDA margin
23.1%
+150% vs 2023
Equity ratio
8.7%
Financial strength
Net profit 2024
SEK 19K
+111% vs 2023
| Revenue | SEK 310K | +38% |
| EBITDA | SEK 72K | +150% |
| Net profit | SEK 19K | +111% |
| Total assets | SEK 3,6M | -3% |
| Equity | SEK 314K | +6% |
| Employees | 0 | — |
Legal name
BioImport 101 AB
Org number
5592936347
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
26 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva utveckling, support, försäljning samt distribution inom området Life Science och därmed förenlig verksamhet.
Address
Solkraftsvägen 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 448 | 224 | 310 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −12 | −123 | −700 | −144 | 72 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −12 | −123 | −700 | −144 | 72 |
| Net financials | — | — | −31 | 17 | 19 |
| Profit before tax | 12 088 | −123 | 68 | −167 | 19 |
| Tax | −2 589 | −0 | −7 | — | — |
| Net profit | 9 499 | −123 | 61 | −167 | 19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 014 | 15 553 | 3 584 | 3 709 | 3 597 |
| Equity | 9 524 | 9 401 | 462 | 295 | 314 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 2 589 | 2 253 | 22 | 3 414 | 3 283 |
| Total debt | 2 589 | 2 253 | 22 | 3 414 | 3 283 |
EBITDA margin
23.1%
This company
15.8%
Market median
+46% vs market
20202024
Equity ratio
8.7%
This company
38.2%
Market median
-77% vs market
20202024
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20202024
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
10.45×
This company
0.62×
Market median
-1585% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-12-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OJ Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BioHolding 101 AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BioHolding 101 AB
BioImport 101 AB Board members of BioImport 101 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ola Joakim Larsson | Audit | 0 companies |
| Stefan Mattias Bergqvist | Board of Directors | 0 companies |
| Sandra Thelberg | Deputy Board Member | 0 companies |
| Anders Runar Holmberg | Chairman | 0 companies |
| Hans Gunnar Samuelsson | Board of Directors | 0 companies |
| Åke Daniel Skantz | Deputy Board Member | 0 companies |
| Anna Sofia Eidefors | Deputy Board Member | 0 companies |